|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| G01N 33/68 | |||
| A61K 39/395 | |||
| A61K 39/00 |
| (11) | Patento numeris | 1991267 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07751993.2 |
| Europos patento paraiškos padavimo data | 2007-03-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2008-11-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/005265 |
| Data | 2007-03-02 |
| (87) | Numeris | WO 2007/103112 |
| Data | 2007-09-13 |
| (30) | Numeris | Data | Šalis |
| 779190 P | 2006-03-03 | US |
| (72) |
YEDNOCK, Theodore, A., US
|
| (73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
| (54) | METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB |
| METHODS OF TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES WITH NATALIZUMAB |